BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 03-Apr-2018

Referring to their earlier news (disseminated by DSE on 08.10.2017) regarding acquiring a majority shareholding (85.22%) in Nuvista Pharma Ltd., the Company has further informed that the Board of Directors of the Company has considered and approved the acquisition of 10,013,474 ordinary shares of Tk. 10.00 each being 85.22% shareholdings of total capital in Nuvista Pharma Limited (formerly Organon Bangladesh Limited), a leading Pharma company in Bangladesh, specializing (cont.)

BXPHARMA 22-Jan-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2017. Post Date: 2018-01-22

BXPHARMA 07-Nov-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

BXPHARMA 26-Oct-2017

The Board of Directors has recommended 12.50% cash dividend for the year ended on June 30, 2017. Date of AGM: 23.12.2017, Time: 10:00 AM, Venue: Beximco Industrial Park, Sarabo, Kashimpur, Gazipur. Record Date: 15.11.2017. (cont.)

BXPHARMA 19-Oct-2017

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 25, 2017 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.

BXPHARMA 08-Oct-2017

The Company has informed that the Board of Directors of the Company has decided to enter into a non-binding Memorandum of Understanding (MOU) under which Beximco Pharma may acquire a majority shareholding (85.22%) in Nuvista Pharma Ltd. a leading pharma Company in Bangladesh specializing in hormones and steroid drugs (the proposed acquisition). The proposed acquisition remains subject to due diligence and negotiation and completion of a definitive Sale and Purchase Agreement. (cont. 1)

BXPHARMA 23-Apr-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

BXPHARMA 22-Jan-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 26, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

BXPHARMA 09-Nov-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2016 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

BXPHARMA 09-Oct-2016

The Board of Directors has recommended 5% final cash dividend for the period of 18 months ended on June 30, 2016 in addition to 10% Interim cash and 5% stock dividend recommended by the Board of the Directors of the Company on April 20, 2016 having record date as May 12, 2016. 10% Interim cash dividend already paid, the cumulative dividend for the period is 15% cash and 5% stock. Date of AGM: 19.11.2016, Time: 10:30 AM, (cont.)

Previous Next page